Shares of Fevertree Drinks PLC (OTCMKTS:FQVTF – Get Rating) have been given an average recommendation of "Hold" by the fourteen research firms that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation and seven have assigned a hold recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $1,261.25.
Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. raised their target price on shares of Fevertree Drinks from GBX 1,100 ($13.35) to GBX 1,200 ($14.57) in a research note on Thursday, December 1st. Berenberg Bank raised their target price on shares of Fevertree Drinks from GBX 1,000 ($12.14) to GBX 1,150 ($13.96) in a research note on Thursday, January 19th. Deutsche Bank Aktiengesellschaft cut their target price on shares of Fevertree Drinks from GBX 780 ($9.47) to GBX 640 ($7.77) in a research note on Tuesday, January 31st. Finally, Liberum Capital downgraded shares of Fevertree Drinks from a "buy" rating to a "hold" rating in a research report on Thursday, January 26th.
Get Fevertree Drinks alerts:Fevertree Drinks Stock Performance
Fevertree Drinks stock opened at $13.20 on Friday. Fevertree Drinks has a one year low of $8.81 and a one year high of $27.15. The firm has a 50-day moving average of $13.05 and a 200-day moving average of $12.03.
About Fevertree Drinks
(Get Rating)
Fevertree Drinks Plc operates as a holding and investment company. It manufactures and supplies premium carbonated mixes. The firm's products include Indian tonic water, Mediterranean tonic water, elderflower tonic water, aromatic tonic water, Clementine tonic water, citrus tonic water lemon tonic water, ginger beer, ginger ale, smoky ginger ale, spiced orange ginger ale, Madagascan cola, Sicilian lemonade, lemonade, and spring soda water.
Featured Articles
- Get a free copy of the StockNews.com research report on Fevertree Drinks (FQVTF)
- Deere Stock Raises Outlook and is Ready to Power Higher
- DraftKings Crowning Achievement: Leverage
- Tesla Stock Comeback Is Picking Up Steam
- How Abbott Labs, AbbVie Could Profit on Seizure Drug Formula
- Is it Time to Fade the Rally in Generac Stock?
Receive News & Ratings for Fevertree Drinks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fevertree Drinks and related companies with MarketBeat.com's FREE daily email newsletter.